| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |